Multiplex cytokine analysis technologies

Expert Review of Vaccines

Volumn 9, Issue 10, 2010, Pages 1231-1237

  Lash, Gendie E ^a   Pinto, Ligia A ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b SAIC FREDERICK INC   (United States)

Author keywords

mRNA arrays; multiplex cytokine analysis; protein arrays; vaccine immunity

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; NEUTRALIZING ANTIBODY;

CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; HUMAN; HYBRIDIZATION; IMMUNITY; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; CYTOKINES; HUMANS; LUMINESCENT MEASUREMENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ARRAY ANALYSIS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; VACCINES;

EID: 77957967368     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.110     Document Type: Review

References (29)

1. Burgess JK. Gene expression studies using microarrays. Clin. Exp. Pharm. Phys. 28, 321.328 (2001).
2. Schulze A, Downward J. Analysis of gene expression by microarrays: cell biologists gold mine or minefield? J. Cell Science 113, 4151.4156 (2000).
3. Katagiri F, Glazebrook J. Overview of mRNA expression profiling using DNA microarrays. Curr. Protocols Mol. Biol. Chapter 22, Unit 22.4 (2009).
4. Diboun I, Wernisch L, Orengo CA, Koltzenburg M. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 7, 252 (2006).
5. Arikawa E, Quelhorst G, Han Y, Pan H, Yang J. RT. Profiler. PCR Arrays: Sensitive, Specific, and Reproducible Quantitative RT-PCR performance. SABiosciences, MD, USA.
6. Arikawa E, Sun Y, Wang J et al. Crossplatform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the microarray quality (MAQC) study. BMC Genomics 9, 328 (2008).
7. Pfleger C, Schloot N, ter Veld F. Effect of serum content and diluents selection on assay sensitivity and signal intensity in multiplex bead-based immunoassays. J. Immunol. Methods 329, 214.218 (2008).
8. Lash GE, Scaife PJ, Innes BA et al. Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight and FAST Quant. J. Immunol. Methods 309, 205.208 (2006).
9. Fu Q, Ahu J, Van Eyk JE. Comparison of multiples immunoassay platforms. Clin. Chem. 56, 314.318 (2010).
10. Chowdhury F, Williams A, Johnson P. Validation and comparison of two multiplex technologies, LuminexR and Mesoscale Discovery, for human cytokine profiling. J. Immunol. Methods 340, 55.64 (2009).
11. Siawaya JF, Roberts T, Babb C et al. An evaluation of commercial fluorescent bead-based luminex cytokine assays. PLoS ONE 3(7), e2535 (2008).
12. Nechansky A, Grunt S, Roitt IM, Kircheis R. Comparison of the calibration standards of three commercially available multiplex kits for human cytokine measurements to WHO standards reveals striking differences. Biomark. Insights 3, 227.235 (2008).
13. Khan IH, Krishnan VV, Ziman M et al. Comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B Clin. Cytom. 76B, 159.168 (2009).
14. Pulendran B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol. 9, 741.747 (2009).
15. Gaucher D, Therrien R, Kettaf N et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205(13), 3119.3131 (2008).
16. Querec TD, Akondy RS, Lee EK et al. System biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10(1), 116.125 (2009).
17. Garcia-Pineres AJ, Hildesheim A, Dodd L et al. Gene expression patterns induced by HPV-16 L1 VLP in leukocytes from vaccine recipients. J. Immunol. 182(3), 1706.1729 (2009).
18. Pinto LA, Castle PE, Roden RB et al. HPV-16 L1 VLP vaccine elicits a broad.spectrum of cytokine responses in whole blood. Vaccine 23, 3555.3564 (2005).
19. Kircheis R, Siegl P, Grunt S et al. Immunization of rhesus monkeys with a SialylTn-mAb17.1A conjugate vaccine co-formulated with QS-21 induces a temporary systemic cytokine release and NK cytotoxicity against tumor cells. Cancer Immunol. Immunother. 56, 863.873 (2007).
20. Burgdorf SK, Claesson MH, Nielsen HJ, Rosenberg J. Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination. Acta Oncol. 48, 1157-1164 (2009).
21. Sariol CA, Munoz-Jordan JL, Abel K et al. Transcriptional activation of interferonstimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin. Vaccine Immunol. 14, 756-766 (2007).
22. McKinney BA, Reif DM, Rock MT et al. Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J. Infect. Dis. 194, 444-453 (2006).
23. Mosca F, Tritto E, Monaci E et al. Molecular and cellular signatures of human vaccine adjuvants. Proc. Natl Acad. Sci. USA 105(30), 10501-10506 (2008).
24. Fang Y, Rowe T, Leon AJ et al. Molecular characterization of in vivo adjuvant activity in influenza-vaccinated ferrets. J. Virol. 84(17), 8369-8388 (2010).
25. Bresson JL, Perronne C, Launay O et al. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: Phase I randomised trial. Lancet 367, 1657-1664 (2006).
26. Nicholson KG, Colegate AE, Podda A et al. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/duck/ Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 357, 1937-1943 (2001).
27. van Gageldonk PG, van Schaijk FG, van der Klis FR, Berbers GA. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J. Immunol. Methods 335(1-2), 79-89 (2008).
28. Smith JF, Kowalski R, Esser MT, Brown MJ, Bryan JT. Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11. Hum. Vaccin. 4(2), 134-142 (2008).
29. Office of Training and Communications Division of Drug Information. Guidance for Industry: Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics. US Food and Drug Administration, MD, USA (2007).